Laurus Labs Limited

Price Chart

Risk-Adjusted Performance

Laurus Labs Limited (LAURUSLABS) Price Performance

Laurus Labs Limited (LAURUSLABS) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR992.60, up 0.55% from the previous close.

Over the past year, LAURUSLABS has traded between a low of INR821.17 and a high of INR1128.50. The stock has gained 18.5% over this period. It is currently 12.0% below its 52-week high.

Laurus Labs Limited has a market capitalization of $565.26B, with a price-to-earnings ratio of 67.10 and a dividend yield of 0.15%.

About Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.